Health groups warn ‘confusing’ post-Roe laws threaten access to some drugs

JAmerican Medical Association and three other health organizations warn ‘confusing’ language in state abortion laws after Supreme Court overturns Roe vs. Wade puts patients’ lives at risk by limiting access to drugs used to treat several conditions.

The AMA, American Pharmacists Association, American Society of Health-System Pharmacists and National Community Pharmacists Association have called on medical boards and state policymakers to provide “clear guidance” on whether certain drugs that cause heart disease Abortion was completely prohibited or could be prescribed for other conditions, such as arthritis.

“Following the United States Supreme Court Dobbs v. Jackson Women’s Health Organization decision, physicians, pharmacists and other healthcare professionals face a confusing legal landscape due to unclear state laws, confusing language and unfamiliar implementation by regulators. and enforcement,” the groups said in a joint statement. “Physicians and pharmacists need clear guidance from state medical and pharmacy boards, agencies, and policy makers to support the prescribing and dispensing of medically necessary drugs that may be affected by this new paradigm. legal and regulatory.

Health groups have argued that the vague language used in some state laws, such as those that prohibit providers from prescribing “abortion-inducing drug,” could also prevent them from prescribing methotrexate, which can be used to terminate a pregnancy but can also be used for other conditions including cancer, ectopic pregnancies and the treatment of inflammatory conditions such as arthritis.

Mifepristone, an abortion-inducing drug, can also be used in emergency circumstances for preeclampsia and other problems that may occur during labor.

Healthcare professionals and patients report that language uncertainty is disrupting care, with emergency contraceptives withheld for victims of sexual assault and pharmacies implementing new policies requiring them to confirm the diagnosis of sexual assault. a patient before prescribing certain drugs, the organizations said.

The organizations urged state medical and pharmaceutical boards and legislatures to provide clarification to ensure patient care would not be further disrupted.

Comments are closed.